13.07.2019 15:41:26
|
Johnson & Johnson Stock Sinks As U.S. Probes Baby Powder
(RTTNews) - The U.S. Justice Department is pursuing a criminal probe into whether Johnson & Johnson (JNJ) lied about possible cancer risks of its talcum powder, the Bloomberg reported, citing people with knowledge of the matter.
Shares of J&J declined by 4.15 per cent to close at US$134.30, following the report.
The criminal probe, which hasn't been reported previously, coincides with a regulatory investigation and civil claims by thousands of cancer patients that J&J's Baby Powder talc was responsible for their illness.
J&J disclosed in its annual report in February that it had received subpoenas from the Justice Department and Securities and Exchange Commission related to the ongoing baby powder litigation.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
21.02.25 |
NYSE-Handel Dow Jones in der Verlustzone (finanzen.at) | |
21.02.25 |
Schwacher Handel in New York: Dow Jones mit Abgaben (finanzen.at) | |
20.02.25 |
Dow Jones aktuell: Dow Jones fällt letztendlich (finanzen.at) | |
20.02.25 |
Anleger in New York halten sich zurück: Dow Jones verliert (finanzen.at) | |
20.02.25 |
Dow Jones-Handel aktuell: Dow Jones notiert im Minus (finanzen.at) | |
19.02.25 |
Pluszeichen in New York: Dow Jones letztendlich mit positivem Vorzeichen (finanzen.at) | |
19.02.25 |
Handel in New York: Dow Jones gibt nach (finanzen.at) | |
19.02.25 |
NYSE-Handel Dow Jones am Mittwochmittag leichter (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 155,26 | 2,29% |
|